Ozanimod for Crohn's Disease
This trial is testing if ozanimod can help control Crohn's Disease.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2017 Phase 3 trial • 1320 Patients • NCT02047734
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are new participants still being sought for this clinical trial?
"That is accurate. The clinical trial in question, which was initially posted on June 27th 2018 according to clinicaltrials.gov, currently has an open call for 485 participants at 100 locations."
How can I qualify to take part in this research?
"Researchers conducting this trial are looking for 485 individuals that have ileocolitis and are between 18-75 years old. Most importantly, applicants should answer the following questions affirmatively: Have you been diagnosed with Crohn's disease?, Have you previously tried a treatment for Crohn's disease which didn't work?, Please confirm that you do not have ulcerative colitis?."
In how many different geographical areas is this trial taking place?
"With 100 hospitals participating, this study has widespread reach. Some of the notable locations include University of Minnesota Medical Center in Minneapolis, NY Scientific in Brooklyn, and University of California at San Francisco in San Francisco."
How many people are being observed for this research project?
"In order to successfully conduct this research, 485 eligible individuals are required to participate. Those who meet the requirements can sign up at University of Minnesota Medical Center in Minneapolis or NY Scientific in Brooklyn."
Does this research include test subjects that are over the age of 30?
"Eligibility for this particular trial is restricted to those aged 18-75. There are 70 other trials underway for patients that fall outside of this age bracket (both younger and older)."
Are there other drugs similar to Ozanimod that have been studied in clinical trials?
"Ozanimod was first studied in 2015 at Local Institution - 554. Since that initial clinical trial, there have been 18302 completed studies. Right now, there are 11 active clinical trials involving ozanimod with a significant number of these occurring in Minneapolis, Minnesota."
When will Ozanimod be available to the public?
"The safety of Ozanimod is estimated to be a 3 on a scale from 1 to 3. This is because it is a Phase 3 trial, which means that there is some data supporting efficacy and multiple rounds of data supporting safety."
Has this type of research been conducted before?
"As of right now, there are 11 ongoing Ozanimod trials in 52 countries and 287 cities. The first study was conducted in 2015 by Celgene. That trial completed Phase 3 drug approval with 2350 patients. Since then, 18302 studies have been concluded."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Most responsive sites:
- PMG Research of Winston-Salem LLC: < 48 hours
Average response time
- < 2 Days